Blog

VC Investing in Philadelphia Hit Record Highs, and Lows, in 2018

March 27, 2019

A new report from PACT and PitchBook shows Philadelphia saw a record year of investments in 2018, when $1.4 billion was poured into local firms, the most in a decade. Released by PACT, the report also documented declines in exits and fundraising by venture capital firms. All put together, though, it depicts a region’s that […]

LeagueSide Expands Nationally; Achieves 400+% Growth In Last 12 Months

March 25, 2019

LeagueSide, the nation’s leading youth sports marketing company enabling regional and national brands to sponsor youth sports leagues, has announced the kickoff of 2019 campaigns for prominent brands, including: Apparent Insurance, CityMD, Comerica, GoGo squeeZ, Noodles and Company, Meiji Hello Panda, Netspend, Popsicle®, Post Consumer Brands, The Franklin Institute and UPMC Health Plan. Based on […]

Why Chef Jose Andres & TGI Friday’s are Using this Philly Restaurant Tech Firm

March 21, 2019

Renowned chefs José Andrés and Michael Solomonov, Philadelphia coffee company La Colombe and national chain TGI Fridays are just a few names using a platform by a growing, venture-backed Philadelphia restaurant technology company now in a Series A round. Three years ago, local entrepreneurs Andy Schwartz, Bhavik Patel and Chaz Brown set out to make […]

Ben Franklin Goes to Harrisburg: Prolific Seed Fund Fighting for ‘Critical’ Funding

March 20, 2019

As a diplomat during the Revolutionary War, Benjamin Franklin spent two years in France trying to convince the French government to fund the American cause. Now an organization that bears his name — and penchant for entrepreneurship — is firing up its own persistent fight for funding. This time, in Harrisburg. Leaders from each of […]

SFA Therapeutics Wins Second Key U.S. Patent For Treatment of Chronic Liver Diseases

March 19, 2019

SFA Therapeutics today announced approval of the second key U.S. patent derived from its research & development program, which utilizes microbiome-derived metabolite small molecules as drugs to modulate the body’s anti-inflammatory and immune systems. As a result of this new patent, targeting Ffar2 (GPR43) and Ffar3 (GPR441) and down-regulation of NF-ĸB, the therapeutic applications of […]